Economy

Needham & Company LLC Reaffirms Buy Rating for Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

(NASDAQ:NBIX) to release earnings on November, 1. Its up 6.51% from 8.57 million shares previously.

Neurocrine Biosciences (NASDAQ:NBIX) last issued its earnings results on Thursday, August 3rd. The lowest price the stock reached in the last trading day was $0.31 and compares with the $0.25 52-week low. The stock had a trading volume of 897,284 shares.

Analysts expect ImmunoGen, Inc.

As of the last earnings report the EPS was $-2.52 and is expected to be $-2.45 for the current year with 88,221,000 shares presently outstanding. Many traders will use a combination of moving averages with different time frames to help review stock trend direction.

Neurocrine Biosciences, Inc is engaged in discovering and developing pharmaceuticals, in diseases with unmet medical needs, through its research and development (R&D) platform, focused on neurological and endocrine based diseases and disorders. The stock's market capitalization is $5.19 billion. The Business's late-stage clinical programs are elagolix, which is a gonadotropin-releasing hormone (GnRH) antagonist in Phase III development for endometriosis and uterine fibroids that is partnered with AbbVie Inc.; INGREZZA (valbenazine), which is a vesicular monoamine transporter 2 (VMAT2) inhibitor, for the treatment of movement disorders, and opicapone, which is a selective catechol-O-methyltransferase (COMT) inhibitor. It now has negative earnings. Its product pipeline also includes NBI-640756 and NBI-74788.

Investors sentiment increased to 1.25 in 2017 Q2. Its up 0.22, from 1.03 in 2017Q1. Vanguard Group Inc. increased its stake in shares of Neurocrine Biosciences by 2.8% in the 2nd quarter. Jgp Global Gestao De Recursos Ltda holds 0.36% or 5,890 shares. First Mercantile Trust Co. boosted its holdings in Neurocrine Biosciences by 22.2% in the first quarter. (NASDAQ:NBIX) has a beta of 0.41. Grt Ltd has 8,169 shares for 0.22% of their portfolio. Proshare Limited Liability Corp reported 47,053 shares.

According to Zacks brokerage recommendations, Neurocrine Biosciences, Inc. Neurocrine Biosciences earned a coverage optimism score of 0.20 on Accern's scale. (NASDAQ:NBIX)'s Buy count is 1 and Strong Buy is 10 while the number of analysts recommending Sell and Strong Sell are 0 and 0, respectively. Citigroup Incorporated reported 0% in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) in a report published on Thursday morning. Moreover, Great West Life Assurance Can has 0% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) opened at 58.83 on Friday. (NASDAQ:NBIX). Meeder Asset Inc reported 0% stake. Next Fincl Grp has 100 shares for 0% of their portfolio. Credit Suisse Ag owns 0.01% invested in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) for 120,500 shares. BidaskClub raised Neurocrine Biosciences from a "sell" rating to a "hold" rating in a research note on Wednesday, June 21st. Therefore 100% are positive. (NASDAQ:NBIX) has risen 12.51% since September 22, 2016 and is uptrending. Jefferies reinitiated Neurocrine Biosciences, Inc. The stock of Neurocrine Biosciences, Inc. Ubs Asset Americas reported 499,947 shares. The rating was maintained by Piper Jaffray with "Overweight" on Thursday, October 8. Needham has "Strong Buy" rating and $40 target. Teachers Advisors LLC now owns 78,287 shares of the company's stock valued at $3,030,000 after purchasing an additional 4,668 shares in the last quarter. The company was maintained on Monday, October 12 by Leerink Swann. Simply put, readings in the range of 80% to 100% indicate that the security is oversold while readings in the 0% to 20% range suggest it is overbought. On Tuesday, May 2 the insider Grigoriadis Dimitri E. sold $550,000. (NASDAQ:NBIX) on Tuesday, May 23. Over the last 90 days, insiders have sold 125,655 shares of company stock valued at $7,018,148. Lippoldt Darin had sold 10,000 shares worth $532,700. Gano Kyle sold 15,000 shares worth $810,000. On Wednesday, July 5 the stock rating was maintained by Oppenheimer with "Buy". J P Morgan Chase & Co set a $57.00 price objective on Neurocrine Biosciences and gave the company a buy rating in a research report on Wednesday, May 24th. The stock has "Sector Perform" rating by RBC Capital Markets on Friday, April 29. Loop Capital initiated WNS (Holdings) Limited (ADR) (NYSE:WNS) on Tuesday, January 10 with "Buy" rating. BMO Capital Markets maintained the shares of NBIX in report on Thursday, August 3 with "Buy" rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.



Like this

Latest


27 September 2017
Weight Loss Saves Obese Adults Nearly $30000
High BMI can also result in high medical costs for treating the complications and productivity losses, due to missed work days. Normal weight, overweight, and obese categories were determined by Body Mass Index standards.

27 September 2017
A-listers t-roll with mean tweets
Jimmy Kimmel's latest round of A-list " Mean Tweets " may be the best yet, thanks to a classic (if crude) comeback. For all that wonderful lifestyle though, they receive thousands of hateful messages every day on social media.

27 September 2017
United Kingdom market access to be sought by top European Union finance firms
A new joint "dispute resolution body" made up of judges and independent experts would rule on breaches of the agreement. In an interview with Reuters , Andrew Bailey, chief executive of the FCA, said: "We haven't had any yet".

27 September 2017
Camila Cabello Is Unfazed By All That Fifth Harmony Shade
Did you love Camila's performance? We mean, Camila was just shining throughout the whole set. She was met by adoring fans and took time to pose for a selfie with the enthusiastic crowd.

27 September 2017
Famous Fake News Writer Found Dead at Age 38
Casey said there was "evidence at the scene" that "suggested this could be an accidental overdose". The Washington Post in 2016 , Horner said he thought Trump won the White House because of him.

27 September 2017
Deloitte Hit by Cyber-Attack, Says 'Very Few Clients' Affected
Deloitte's statement did not say when the attack took place or who was targeted. "This trend is going to continue to grow". The company did not name the clients, confirm the number of clients it had contacted or say what type of data was stolen.

27 September 2017
Warner Bros Apologise For Shadow Of War DLC Confusion
"For absolute clarity; our intention was always to give all profits from the DLC , worldwide to the Forgey family", Warner Bros . The update also states that ALL profits from the DLC , worldwide, would have gone to Forgey's family under the original plan.

27 September 2017
Fifth Third Bancorp (NASDAQ:FITB) Shares Sold by Axa
The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink . TheStreet upgraded Fifth Third Bancorp from a "c+" rating to a "b" rating in a research report on Friday, June 23rd.

27 September 2017
Clean Energy Fuels Corp. (NASDAQ:CLNE) Experiences Light Trading Volume
ILLEGAL ACTIVITY WARNING: This news story was originally posted by Week Herald and is the sole property of of Week Herald. The company's Average Earnings Estimate for the Current Fiscal quarter is $-0.13, according to consensus of 3 analysts.

27 September 2017
Chicago Sees Heat Wave Unlike Any Other for This Time of Year
Lebanon, New Hampshire also has a shot at an official heat wave and a lot of other cities and towns will shatter record highs. According to the weather service, the warmth continues through midweek before dropping into the high 70s on Thursday .



Recommended